We use our own and third-party cookies to optimize your experience on this site, including to maintain user sessions. Without these cookies our site will not function well. If you continue browsing our site we take that to mean that you understand and accept how we use the cookies. If you wish to decline our cookies we will redirect you to Google.
Already have an account? Sign in.

 Remember Me | Forgot Your Password?

Competition Heats Up In Krill And Functional Fish Oil Markets

September 3, 2010: 10:50 PM EST
New York private equity firm Lindsay Goldberg has purchased half of the outstanding shares of Norwegian krill supplier Aker BioMarine to form a joint venture, NewCo, which in turn bought fish oil supplier EPAX. Also a Norwegian company, EPAX provides fish oils with variable concentrations of omega-3s EPA and DHA, targeting specific health conditions. Industry observers hope the new market strength of Aker will spur it to greater investment in clinical trials for its fish oil supplements. Krill pioneer Neptune Technologies & Bioressources has had its fish oil tested successfully against competitive brands in studies of PMS and dysmenorrhea, arthritis inflammation and pain, and regulation of blood lipids. Meanwhile, Azantis, another major competitor, is broadening its R&D to create a water-soluble krill that might be useable in beverages.
Todd Runestad, "Industry analysis: Aker Lands Epax", Functional Ingredients, September 03, 2010, © Penton Media Inc
North America
United States of America
Comment & Opinion
Companies, Organizations
Deals, M&A, JVs, Licensing
Market News
Products & Brands
Developed by Yuri Ingultsov Software Lab.